Featured Jobs
|
Strongpoint Partners
|
|
Cash Balance/ Defined Benefit Plan Administrator Steidle Pension Solutions, LLC
|
|
Regional Vice President, Sales MAP Retirement USA LLC
|
|
Retirement Plan Administration Consultant Blue Ridge Associates
|
|
Managing Director - Operations, Benefits Daybright Financial
|
|
Relationship Manager for Defined Benefit/Cash Balance Plans Daybright Financial
|
|
Retirement Plan Consultants
|
|
Compass
|
|
July Business Services
|
|
DC Retirement Plan Administrator Michigan Pension & Actuarial Services, LLC
|
|
Anchor 3(16) Fiduciary Solutions
|
|
Mergers & Acquisition Specialist Compass
|
|
Combo Retirement Plan Administrator Strongpoint Partners
|
|
ESOP Administration Consultant Blue Ridge Associates
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
Biden Administration Pushes Anti-Obesity Drug Pressure to Trump
AXIOS; registration may be required 
Nov. 27, 2024 "The Biden administration's move, which would take effect in 2026, would expand access to drugs like Novo Nordisk's Ozempic or Wegovy for 3.4 million Americans on Medicare ... Officials said they do not expect this would raise seniors' premiums.... It's unclear how the Trump administration will view Medicare coverage of GLP-1s.... The cost is expected to be a key sticking point, particularly as the administration promises to cut back federal spending[.]" MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |